EI- Nile Co. for Pharmaceuticals and Chemical Industries (EGX:NIPH)

EGX:NIPH Ratios and Metrics

Market cap in millions EGP. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	467	699	405	359	354	309
Market Cap Growth	-40.12%	72.69%	12.78%	1.40%	14.77%	60.88%
Enterprise Value	1,284	1,009	670	317	305	310
Last Close Price	46.10	25.68	13.85	11.25	10.32	8.70
PE Ratio	5.05	7.75	3.40	4.00	5.50	3.30
PS Ratio	0.45	0.61	0.40	0.41	0.47	0.38
PB Ratio	0.63	1.49	0.85	0.83	0.95	0.91
P/TBV Ratio	0.63	1.49	0.85	0.83	0.95	0.91
P/FCF Ratio	-	-	-	-	4.72	6.93
P/OCF Ratio	14.45	2.65	-	73.13	4.46	6.21
EV/Sales Ratio	1.23	0.88	0.67	0.36	0.40	0.38
EV/EBITDA Ratio	7.07	6.49	1.36	2.28	2.84	2.36
EV/EBIT Ratio	7.75	7.03	4.11	2.53	3.19	2.66
EV/FCF Ratio	-2.59	-	-	-	4.07	6.95
Debt / Equity Ratio	1.11	1.23	0.44	0.19	0.12	0.13
Debt / EBITDA Ratio	4.54	3.70	0.43	0.57	0.40	0.33
Debt / FCF Ratio	-	-	-	-	0.58	0.99
Asset Turnover	0.62	0.91	1.11	1.18	1.08	1.30
Inventory Turnover	2.17	2.08	2.26	2.62	2.09	2.36
Quick Ratio	0.55	0.35	0.47	0.57	0.74	0.52
Current Ratio	1.08	1.28	1.75	1.81	1.75	1.66
Return on Equity (ROE)	14.71%	19.05%	26.22%	22.36%	18.16%	31.88%
Return on Assets (ROA)	6.08%	7.14%	11.25%	10.53%	8.54%	11.60%
Return on Capital (ROIC)	8.13%	10.34%	16.93%	16.95%	15.00%	20.66%
Return on Capital Employed (ROCE)	16.00%	17.80%	30.10%	28.90%	25.50%	34.20%
Earnings Yield	19.82%	12.90%	29.44%	24.98%	18.19%	30.27%
FCF Yield	-106.33%	-22.25%	-70.16%	-12.21%	21.21%	14.43%
Dividend Yield	8.05%	14.45%	36.11%	26.40%	19.38%	-
Payout Ratio	58.96%	71.36%	34.95%	37.13%	70.73%	-
Total Shareholder Return	8.05%	14.45%	36.11%	26.40%	19.38%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.